|4Feb 4, 7:38 PM ET

Mazar Andrew Paul 4

4 · Monopar Therapeutics · Filed Feb 4, 2022

Insider Transaction Report

Form 4
Period: 2022-02-02
Transactions
  • Award

    Stock Options

    2022-02-02+88,87488,874 total
    Exercise: $2.80Exp: 2032-02-01Common Stock (88,874 underlying)
  • Award

    Restricted Stock Units

    2022-02-02+67,25190,398 total
    Exercise: $0.00Common Stock (67,251 underlying)
Footnotes (2)
  • [F1]Options vest 6/48ths on June 30, 2022 and 1/48ths per month thereafter.
  • [F2]RSUs vest 6/48ths on June 30, 2022 and 3/48ths per quarter thereafter (September 30, 2022, December 31, 2022, March 31, 2023, June 30, 2023, September 30, 2023, December 31, 2023, March 31, 2024, June 30, 2024, September 30, 2024, December 31, 2024, March 31, 2025, June 30, 2025, September 30, 2025, December 31, 2025)

Documents

1 file
  • 4
    section16.xmlPrimary

    PRIMARY DOCUMENT